Density and localization of calcium channels of the L-type in human pulmonary artery

Clinical and Experimental Hypertension

Volumn 20, Issue 4, 1998, Pages 389-402

  Amenta, Francesco ^a,d   Bisetti, Alberto ^b   Bronzetti, Elena ^b   Coppola, Luigi ^c   Felici, Laura ^b   Ferrante, Fabio ^b   Mariotta, Salvatore ^b   Ricci, Alberto ^b  

^a UNIVERSITY OF CAMERINO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SAN FILIPPO NERI HOSPITAL   (Italy)

^d Dipto Sci Farmacologiche Med S   (Italy)

Author keywords

Autoradiography; Calcium channels; Dihydropyridines; Human pulmonary artery; Nicardipine; Radioligand binding

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; CINNARIZINE; DILTIAZEM; FLUNARIZINE; ISRADIPINE; NICARDIPINE; NIFEDIPINE; VERAPAMIL;

ADULT; AGED; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSOCIATION CONSTANT; HUMAN; HUMAN TISSUE; LIGAND BINDING; MALE; PULMONARY ARTERY; PULMONARY HYPERTENSION; RENAL ARTERY; RIGHT CORONARY ARTERY;

EID: 0031838639     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969809053220     Document Type: Article

References (22)

1. Nayler WG: Calcium Antagonists. Academic Press Oxford London, 1989.
2. Watson, S., Girdlestone, D. Receptor and ion channel nomenclature. Trends Pharmacol. Sci. 1995; (Suppl)1: 1-71.
3. Fleckenstein, A. Calcium Antagonism in Heart and Smooth Muscle. J. Wiley and Sons , Inc. New York, 1983.
4. Triggle, D.J. Sites, mechanism of action and differentiation of calcium channel antagonists. Am. J. Hypertens. 1991; 4: 422s-429s.
5. Packer, M. Therapeutic application of calcium-channel antagonists for pulmonary hypertension. Am. J. Cardiol. 1985; 55: 196b-201b.
6. Rich, S., Kaufman, E. High dose titration of calcium channel blocking agents for primary pulmonary hypertension: guidelines for short -term drug testing. J. Am. Coll. Cardiol. 1991; 18: 1323-1327.
7. Rich, S., Kaufman, E., Levy, P.S. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N. Engl. J. Med. 1992; 327: 76-81.
8. Rubin, L.J. Primary pulmonary hypertension. Practical therapeutic recommendations. Drugs 1992; 43: 37-43.
9. Hilbert, G., Marthan, R., Vergeret, J., Taytard, A. Calcium antagonists and chronic obstructive broncho-pneumopathies. Rev. Mal. Respir. 1989; 6: 209-214.
10. 3H] nicardipine binding sites in the human renal artery. Eur. J. Pharmacol. 1993; 240: 229-234.
11. Ferrante, F., Cadoni, A, Zaccheo, D., Amenta, F. Localization of calcium channels of the L-type in human epicardial arteries : a light microscope autoradiographic study. Clin. Exper. Hypertension 1995 ;17 :895-912.
12. 3H]-SCH 23390 as a ligand. J. Auton. Pharmacol. 1990; 10:373-383.
13. 50) of an enzyme reaction. Biochem. Pharmacol. 1973; 22: 3099-3103.
14. Simonneau, G., Escourrou, P.., Duroux, P., Lockart, A. Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. N. Engl. J. Med. 1981; 304: 1582-1585.
15. Galloe, A.M., Graudal, N., Petersen, J.R., Leth, P., Galloe, M. The effect of the calcium antagonist isradipine, on working capacity, pulmonary function, morbidity and survival rate in patients with severe chronic obstructive pulmonary disease (COPD): a randomized, double-blind, placebo-controlled study. J. Intern. Med. 1991; 229: 447-452.
16. Rich, S., Brundage, B.H. High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure. Circulation 1987; 76: 135-14.
17. Young, T.E., Lundquist, L.J., Chesler, E. Comparative effects of nifedipine, verapamil and diltiazem on experimental pulmonary hypertension. Am. J. Cardiol. 1983; 51: 195-200.
18. Spedding, M., Paoletti, R. Classification of calcium channels and the sites of action of drug modifying channel function. Pharmacol. Rev. 1992; 44: 363-378.
19. Schwartz, A., Triggle, D.J. Cellular action of calcium channel blocking drugs. Ann. Rev. Med. 1984; 35: 336-352.
20. Xiong, Z., Sperelakis, N. Regulation of L-type calcium channels of vascular smooth muscle cells. J. Mol. Cell. Cardiol. 1995; 27: 75-91.
21. 2-like receptors in pulmonary artery of the human and rabbit but not of the rat. Eur. J. Pharmacol. 1994; 261: 229-236.
22. O'Neill, S.K., McKay, D.W., Campbell, N., Triggle, C.R., Crowley, M., Bolger, G.T. Comparative behavioural, neurochemical and pharmacological activities of dihydropyridine calcium channel activating drugs. J. Pharmacol. Exp. Ther. 1990; 253: 905-914.